Filter by: patients
Home > Community Treatment Reports and Side Effects > Adalimumab Treatment Report
What is Adalimumab?

Adalimumab is used in the treatment of active rheumatoid arthritis and active psoriatic arthritis. Also used for Crohn's disease in patients with inadequate response to conventional treatment.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
RA (Rheumatoid Arthritis) 67 19 Efficacy_major Efficacy_moderate Efficacy_slight
Crohn's Disease 26 8 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Psoriasis 16 5 Efficacy_major Efficacy_slight Efficacy_none
Ankylosing Spondylitis 11 1 Efficacy_slight
Psoriatic arthritis 8 1 Efficacy_slight
Rheumatoid Arthritis 6 1 Efficacy_cant_tell

See all 130 patients currently taking Adalimumab

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 4
Moderate
 8
Mild
 10
None
 17

Commonly reported side effects, conditions, and hospitalizations associated with Adalimumab

Injection site reaction 4
Muscle fatigue 2
Nausea 2
Pneumonia 1
Headaches 1
Tremor in legs 1
See all 31 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Adalimumab. See all 14 dosages ►

  40mg/0.8mL as needed 40 mg/0.8 mL monthly 20 mg/0.4 mL every other week 20 mg/0.4 mL weekly 40 mg every other week 40 mg/0.8 mL every other week 2 x 40 mg/0.8 mL every other week 40 mg/0.8 mL weekly 2 x 40 mg/0.8 mL weekly 10 x 40 mg/0.8 mL monthly
  2 Number of Patients: 2 2 Number of Patients: 2 6 Number of Patients: 6 2 Number of Patients: 2 1 Number of Patients: 1 102 Number of Patients: 102 1 Number of Patients: 1 15 Number of Patients: 15 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Adalimumab (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 23   Did not seem to work: 50%
Side effects too severe 14   Side effects too severe: 30%
Doctor's advice 12   Doctor's advice: 26%
Other 11   Other: 24%
Expense 3   Expense: 7%
Change in health plan coverage 2   Change in health plan coverage: 4%
Not indicated 2   Not indicated: 4%
Personal research 1   Personal research: 2%

See all 46 patients who’ve stopped taking Adalimumab

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Adalimumab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Adalimumab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Adalimumab

Always
 33 85%
Usually
 5 13%
Sometimes
 0 0%
Never
 1 3%

Burden

Difficulty being on treatment

Burden of Adalimumab

Very
 3 8%
Somewhat
 9 23%
A little
 9 23%
Not at all
 18 46%

Cost

Paid out of pocket

Cost of Adalimumab

$200+
 3 11%
$100-199
 0 0%
$50-99
 3 11%
$25-49
 2 7%
< $25
 20 71%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.